Stem Cell Treatment for you in 2015. Areference for physicians, patients and Review of International Stem Cell Treatment centers

Dan Mfanfikile Gama

Abstract


Stem cell reserves diminish with aging and we no longer effectively heal, with chronic illness being the result. With adequate numbers of stem cells the body is expected to heal naturally. Here we provide information and reference to both patients and doctors on therapeutic use of stem cells, treatment centers around the world, addresses, contact persons, treatment cost, and sources of stem cells used, type of conditions being treated and the protocols used. The treatment centers were directly contacted through email, phone call or through their web page. 11 treatment centers responded from 8 different countries with 4 in the USA alone, 4 treatment centers recommended by the Repair Stem Cell Institute which is the biggest patient advocate. Most treatment centers are outside the USA because of strict stem cell treatment regulatory laws within the USA. All the 11 Treatment Centers that responded were able to provide their contact details, source of Stem Cells being used and medical conditions being treated.

Such information will provide good guidance to both Physicians and patients who want to consider Stem Cell Treatment. It is hoped that more stem cell treatment centers will be reported about in the next publication as therapeutic stem cell regulatory laws become less strict especially in the USA.


Keywords


Pluripotent; Embryonic Stem Cells; Fetal Stem Cells; Adult Stem Cells; Mesenchymal Stem Cells; Hematopoietic Stem Cells.

Full Text:

PDF

References


Akimoto Nimura, Koji Otabe, Hedeyuki Koga, Young-Jin Jun: Analysis of Human synovial and bone marrow mesenchymal stem cells in relation to heat-inactivation of autologous and fetal bovine serums. BMC Musculoskeletal Disorders 2010, 11:208

Andrew JG, Hoyland JA, Freemont AJ et al.: Platelet derived growth factor expression in normally healing human fractures. Bone. 1995 16: 455-460.

Canango PM, Lekovie V, Weinlaender M, et al.: Platelet- rich plasma and bovine porous bone mineral combined with guided tissue regeneration in the treatment of intrabony defects in humans. J Periodontal Res. 2002 37:300-3006.

Christopher J. Centeno: The Stem Cells they dont want you to have. 2012

Elizabeth Csaszar, Daniel C. Kirouac, Mei Yu, Weijia Wang, Wenlian Qiao: Rapid Expansion of Human Hematopoietic Stem Cells by Automated Control of Inhibitory Feedback Signaling

Friedenstein AJ, Petrakova KV, Kurolesova AI, et al.: Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation 6:230-247. Garg AK,: The use of Platelet-rich plasma to enhance the success of bone grafts around dental implants. Dent Implantol Update. 2000, 11:17-21.

Garg AK,: The use of Platelet-rich plasma to enhance the success of bone grafts around dental implants. Dent Implantol Update. 2000, 11:17-21. Hakimi M, Jungbluth P, Sager M, et al.: Combined use of platelet-rich plasma and autologus bone grafts in the treatment of long bone defects in mini-pigs. Injury. 2010, 41:717-723.

Ichiro Sekiya, Benjamin L. Larson, Jason R. Smith, Radhika Pochampally, Jian-Guo Cui, Darwin J. Prockop: Expansion of Human Adult Stem Cells from bone marrow stroma: conditions that maximize the yields of early progenitors and evaluate their quality.2002. DOI:10.1634/stemcells.20-6-530

Jennifer Antonchuk, Guy Sauvageau, Keith Humphries: HOXB4-Induced Expansion of Adult Hematopoietic Stem Cells ex vivo. Cell, Vol. 109, 39-45 April 5, 2002 Joyce ME, Jingushi S, Bolander ME,: Transforming growth factor-beta in the regulation of fracture repair. Orthop Clin North AM. 1990, 21: 199-209.

Marcola et al: Case Dismissed! Texas ends 15 year fight against cancer doctor Burzynski.January19, 2013. Marcola.com: 364, 332

Melanie Vogl, Johannes Fischer, Marcus Jager, Christoph Zilkens, Rudiger Krauspe, Monika Herten: Can thrombin-activated platelet releasate compensate the age-induced decrease in cell proliferation of MSC? June 2013.DOI 10.1002/jor.22433.

Michael Freeman, Mitchell Fuerst: Does the FDA have regulatory authority over adult autologous stem cell therapies? 21 CFR 1271 and the emperors new clothes. Freeman and Fruerst Journal of Transplantational Medicine 2012, 10:60

Neil Riordan, Kyle Chan, Annette M. Marleau, Thomas E. Ichim; Cord blood in regenerative medicine: do we need immune suppression? Journal of Transfusion Medicine 2007, 5:8 doi: 10.1186/1479-5876-5-8

Patricia A. Zuk, Min Zhu, Peter Ashjian, Daniel A. DeUgarte, Jerry I. Huang, Hiroshi Mizuno, Zeni C. Alfonso, John K. Fraser, Prosper Benhaim, and Marc H. Hedrick: Human Adipose Tissue is a source of Multipotent Stem Cells. Mol Bio Cell. 2002 Dec. 13(12): 4279-4295.

Suphachai Chaithiraphan, Somchai Dutsadeevettakul, Suttipong Tasneeyapant, Demras Tresukosol, Chunhakasun Chotinaiwattarakul, Vithaya Chaithiraphan; Transcoronary injection of Angiogenic cells precursors of Autologous Stem Cells in Ischemic Cardiomyopathy: a clinical study of 106 cases in Thailand. Asean Heart Journal Jan. 2009 Vol. 17 No. 1

Vanderson Rocha, Myriam Labopin, Guillermo Sanz, William Arcese, Rainer Schwerdtfeger, Alberto Bosi, Niels Jacobsen, Tapani Ruutu, Marcos de Lima, Jurgen Finke, Francesco Frassoni, Eliane Gluckman: Transplants of Umbilical-Cord Blood or bone marrow from unrelated donors in adults with acute leukemia. N Engl j.Med 2004; 351:2276-85


Refbacks

  • There are currently no refbacks.


 

 
  
 

 

  


About IJSBAR | Privacy PolicyTerms & Conditions | Contact Us | DisclaimerFAQs 

IJSBAR is published by (GSSRR).